dr. sonpavde on combining vegf/pd-1 inhibitors in metastatic urothelial carcinoma
Published 4 years ago • 80 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
0:50
dr. sonpavde on immunotherapy combination studies in urothelial carcinoma
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
1:27
dr. mcdermott on vegf/pd-1 inhibition in rcc
-
0:47
copy of dr. sonpavde on key data with immunotherapy in metastatic bladder cancer
-
0:53
dr. sonpavde on immunotherapy plus chemotherapy in bladder cancer
-
1:25
dr. sonpavde on the next steps for atezolizumab in urothelial carcinoma
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
1:26
dr. sonpavde on remaining questions with immunotherapy in bladder cancer
-
0:52
dr. sonpavde on trials of immunotherapy in bladder cancer
-
1:49
dana-farber cancer institute: guru sonpavde, md at asco gu21 (urothelial carcinoma)
-
1:24
dr. sonpavde on neoadjuvant immunotherapy in bladder cancer
-
3:41
outcomes of pts w/metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin
-
1:19
dr. sonpavde on key data with immunotherapy in metastatic bladder cancer
-
2:07
dana-farber cancer institute: guru sonpavde, md (bladder cancer research at asco gu21)
-
1:43
dr. sonpavde discusses a study of fixed-dose durvalumab and tremelimumab in urothelial carcinoma
-
1:05
dr. sonpavde on the biggest challenges in bladder cancer
-
4:43
ctdna analysis may help to personalize metastatic urothelial carcinoma treatments | guru sonpavde
-
0:57
combined inhibition of parp and vegf in gastric cancer
-
2:07
dr. sonpavde on emerging immunotherapy approaches in bladder cancer